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Purification Process Development of Protein Subunit based 
Vaccine Candidates Produced using Recombinant E. coli 
Expression System- Case-Study
Introduction to Case study
Challenges with two peaks in RP_HPLC
•Different batches have different peak 1/peak 2 ratio
•This ratio changes over time
•Peak 2 gets converted to peak 1 over time
•It is hard to use RP_HPLC assay to quantify and measure purity 
Stability indicating assay
•However, it has no impact on biological activity 
•Mixture of two proteins has no impact on immunogenicity
Problem: Appearance of two peaks in the purified protein product
(protein Y) in RP_HPLC assay (Figure 6) and ratio changes over 
time.
Objective: To obtain product consistency-Protein Y
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Figure 8: Diafiltration in the presence of antioxidants e.g. 
methionine and thiosulfate results into majority of peak 2
Figure 10: Forced Oxidized form has lower activity than reduced form, 
however, natural shift over time doesn’t change activity
Figure 6: Purified Protein Y runs as two peaks in RP_HPLC, Peak 1 (21.8 
min) has lower retention time than peak 2 (22.6 min) in RP HPLC
Figure 12: Titration of Oxidation reaction with 
different amounts of Periodate indicate that 10-
50 um of Periodate is sufficient
SM1= 2 column purified
SM2= 3 column purified
Effect of Oxidizing agents and 
antioxidants on the two peaks •Peak 1 is more oxidized form of Peak 2
•Oxidation process is irreversible
•Peak 2 only can be generated by including oxidation inhibitors
•Peak 1 only can be generated by oxidizing agents
•Purified product made could be prepared consistently with a 
single peak (peak 1 or peak 2)
Part II
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Figure 7: SDS-PAGE analysis of Peak 1 and Peak 2 fraction showed that they have 
similar molecular weight
No Treatment, 65% Peak 1, 34% Peak 2 
20 mM Methionine, 4% peak 1, 95% peak 2
12 mM Thiosulfate, 13% Peak 1, 86% Peak 2
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Figure 9: Protein Y can be Oxidized with Periodate 
treatment to Peak 1
Treatment with %Peak1 vs. 
%Peak2
Biological 
Activity
Immunological 
Activity
None* 6 /94 +++ Yes
None 73 /19 +++ Yes
20 mM Methionine 4 / 96 ++++ Yes
12 mM Thiosulphate 13 / 87 ++++ Not done
10 mM Sodium 
Periodate
100 / 0 + Yes
10 um Periodate 99 / 0 + Yes
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Figure 11: Oxidized Protein Y with 10 mM Periodate: shift in the 
retention time observed by 0.5 min on RP_HPLC
3rd column
Elution % Peak -1 % Peak 1 % Peak 2
RT 21.4 RT 21.8 RT 22.6
No NaIO4 0 41 58
63
19
8
0
0
89
9
1 uM NaIO4 0 37
5 uM NaIO4 0 81
10 uM NaIO4 0 91
50 um NaIO4 0 100
250 um NaIO4 44 56
1 mM H2O2 0 11
100 mM H2O2 48 35
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Figure 13: For 5 uM of Protein Y (1.5% is Met or 
0.075 um of Met), you need 10-50 uM of NaIO4
Conclusions
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Peak 1 appears only after during last 
diafiltration step in the process
